World-first IVF trial targets immune system
A world-first IVF trial led by national fertility clinic Genea is investigating whether the immune system, specifically natural killer cells, is a factor in repeated failed IVF attempts and recurrent miscarriages. The trial will recruit up to 1,600 patients nationally, using a simple blood test to identify if natural killer cell activity is abnormal. The research aims to help women who experience recurrent implantation failure, affecting 10-15% of IVF patients, by potentially allowing doctors to modify the immune environment before embryo transfer.See omnystudio.com/listener for privacy…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.